Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The cosmetics business reported lower sales and lower profit due to unfavorable weather and rising CPA. In the beauty and wellness business, sales events and e-commerce sales contributed, while the operating loss narrowed as selling, general and administrative expenses were controlled. The regenerative medicine-related business reported higher sales and profit due to increased orders for cell processing and OEM services, bringing forward scheduled orders, and reviewing research and development expenditures. In the investment business, ordinary revenue was at the same level as the previous year, but a provision for an allowance for doubtful accounts was recognized in connection with the discontinuation of the biomass power generation business. Across the Company, measures including business structure reforms, relocation of the head office, and the dissolution of 株式会社アルヌール were implemented.
Disclosure regarding material events and conditions is included. Although events or conditions exist that raise substantial doubt about the Company's ability to continue as a going concern due to the operating loss, interim net loss attributable to owners of the parent, and negative cash flows from operating activities, the Company has determined that no material uncertainty regarding the going-concern assumption exists as a result of its measures. There are no applicable notes regarding the going-concern assumption.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | 1,202 Millions of yen (YoY -5.0%) |
| Operating profit | -198 Millions of yen |
| Ordinary income | -403 Millions of yen |
| Profit attributable to owners of the parent | -444 Millions of yen |
| Net income per share | ¥(5.37) |
| Equity ratio | End of the current fiscal period 64.8 / End of previous period 75.4 |
| Total assets | 2,257 Millions of yen |
| Net assets | 1,461 Millions of yen |
| Cash flows from operating activities | ¥-379,121 thousand |
| Cash flows from investing activities | ¥144,548 thousand |
| Cash flows from financing activities | ¥250,000 thousand |
| Cash and cash equivalents at end of period | ¥372,627 thousand |
| Full-year earnings forecast | Net Sales 2,444 Millions of yen (YoY -14.6%) / Operating profit -277 Millions of yen / Ordinary income -489 Millions of yen / Net income -525 Millions of yen |
| Revision to Earnings Forecast | Not disclosed → Net Sales 2,444 / Operating profit -277 / Ordinary income -489 / Net income -525 |
| Annual Dividend Forecast | 0 Yen → 0 Yen（0.0%） |
| Segment revenue | Cosmetics business ¥503,168 thousand / Beauty and wellness business ¥439,296 thousand / Regenerative medicine-related business ¥238,570 thousand / Sustainable business ¥1,697 thousand / Investment business ¥19,999 thousand |
| Segment profit | Cosmetics business ¥-104,025 thousand / Beauty and wellness business ¥-19,297 thousand / Regenerative medicine-related business ¥44,474 thousand / Sustainable business ¥-26,245 thousand / Investment business ¥19,570 thousand |
| Depreciation and amortization | ¥4,317 thousand |
| Impairment loss | ¥19,905 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income None / Extraordinary loss Impairment loss ¥19,905 thousand, Relocation expenses ¥15,583 thousand, Other ¥772 thousand |
| Disclosure regarding the going concern assumption | Disclosure regarding material events and conditions is included. Although events or conditions exist that raise substantial doubt about the Company's ability to continue as a going concern due to the operating loss, interim net loss attributable to owners of the parent, and negative cash flows from operating activities, the Company has determined that no material uncertainty regarding the going-concern assumption exists as a result of its measures. There are no applicable notes regarding the going-concern assumption. |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 companies / Excluded 1 company / Company name 株式会社RIDO Stock |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Whether applicable None / Subject person Not disclosed |
| Issued Shares at Period-End | 82,680,236 shares |
| Treasury Shares at Period-End | — shares |
| Factors Behind Changes in Business Performance | The cosmetics business reported lower sales and lower profit due to unfavorable weather and rising CPA. In the beauty and wellness business, sales events and e-commerce sales contributed, while the operating loss narrowed as selling, general and administrative expenses were controlled. The regenerative medicine-related business reported higher sales and profit due to increased orders for cell processing and OEM services, bringing forward scheduled orders, and reviewing research and development expenditures. In the investment business, ordinary revenue was at the same level as the previous year, but a provision for an allowance for doubtful accounts was recognized in connection with the discontinuation of the biomass power generation business. Across the Company, measures including business structure reforms, relocation of the head office, and the dissolution of 株式会社アルヌール were implemented. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the cosmetics business, sales remained sluggish due to unfavorable weather and rising CPA. The operating loss narrowed as selling, general and administrative expenses, including rent and advertising expenses, were reduced. However, the ordinary loss widened, mainly due to the ¥234 million provision for an allowance for doubtful accounts associated with the discontinuation of the biomass power generation business. The full-year forecast was revised due to the recognition of extraordinary losses.